Opus Genetics, Inc. (IRD)

Opus Genetics Revenue

Opus Genetics had revenue of $3.87M in the quarter ending September 30, 2024, a decrease of -67.60%. This brings the company's revenue in the last twelve months to $8.38M, down -85.35% year-over-year. In the year 2023, Opus Genetics had annual revenue of $19.05M, down -52.20%.

• Revenue (ttm): $8.38M
• Revenue Growth: -85.35%
• P/S Ratio: 2.90
• Revenue / Employee: $598,643
• Employees: 14
• Market Cap: 30.89M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	19.05M	-20.80M	-52.20%
Dec 31, 2022	39.85M	39.26M	6,665.70%
Dec 31, 2021	589.00K	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.